Bio-Rad Labs (BIO) Acquires Propel Labs' High Performance Flow Cytometer Platform
Tweet Send to a Friend
Bio-Rad Laboratories, Inc. (NYSE: BIO) and Propel Labs announced that Bio-Rad has acquired a high performance analytical flow cytometer platform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
